Direct immunofluorescence in the diagnosis of scleroderma syndromes
- 1 March 1977
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 96 (3) , 231-238
- https://doi.org/10.1111/j.1365-2133.1977.tb06130.x
Abstract
Immunofluorescent study of the skin of nine patients with mesenchymal, inflammatory scleroderma (mixed connective tissue disease) revealed immunoglobulin and complement deposition at the basement membrane or within blood vessel walls. The skin specimens of ten patients with systemic scleroderma were negative for immunofluorescence. It is proposed that basement membrane or vascular (or both) immunofluorescence is an excellent means of identifying the infrequent patient who has scleroderma and myositis or lupus erythematosus in whom a corticosteroid response may occur.This publication has 9 references indexed in Scilit:
- Cutaneous Immunopathology: Recent ObservationsJournal of Investigative Dermatology, 1975
- Pathogenesis and staging of sclerodermaActa Dermato-Venereologica, 1975
- Immunoglobulin in Clinically Uninvolved Skin in Systemic Lupus Erythematosus ASSOCIATION WITH RENAL DISEASEJournal of Clinical Investigation, 1974
- Survival with scleroderma—II: A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patientsJournal of Chronic Diseases, 1973
- Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)Published by Elsevier ,1972
- Survival in scleroderma.Annals of the Rheumatic Diseases, 1971
- Immunofluorescent "band" test for lupus erythematosus. II. Employing skin lesionsArchives of Dermatology, 1970
- An immunofluorescent study of the skin lesions in systemic lupus erythematosusArthritis & Rheumatism, 1966
- Prognostic Significance of Raynaud's Phenomenon and Other Clinical Characteristics of Systemic SclerodermaCirculation, 1960